Assessment of vitamin K deficiency in CF - How much sophistication is useful?

Journal of Cystic Fibrosis

Volumn 2, Issue 2, 2003, Pages 91-96

  Mosler, Katharina ^a   von Kries, Rüdiger ^b   Vermeer, Cees ^c   Saupe, Jörg ^d   Schmitz, Thomas ^a   Schuster, Antje ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Virchow University   (Germany)

Author keywords

Cystic fibrosis; HBC; Osteopenia; PIVKA II

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CALCIUM; CORTICOSTEROID DERIVATIVE; DECARBOXYPROTHROMBIN; HYDROXYAPATITE; PHYTOMENADIONE; TRIACYLGLYCEROL LIPASE; VITAMIN D; VITAMIN K GROUP;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD CLOTTING TEST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE MARKER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; MALABSORPTION; MALE; OSTEOPENIA; PANCREAS INSUFFICIENCY; PROTHROMBIN TIME; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SWEAT TEST; VITAMIN BLOOD LEVEL; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; INFANT; LIPASE; MASS SCREENING; OSTEOCALCIN; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; PROTHROMBIN; PROTHROMBIN TIME; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; VITAMIN K; VITAMIN K DEFICIENCY;

EID: 0037971981     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(03)00025-0     Document Type: Article

References (22)

1. Sokol R.J. Reardon M.C. Stall C. Narkewicz M. Abman S.H. Hammons K.B. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns Am J Clin Nutr 50 1989 1064-1071
2. Wilson D.C. Rashid M. Durie P.R. Tsang A. Kalnins D. Andrew M. Corey M. Shin J. Tullis E. Pencharz P.B. Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination J Pediatr 138 2001 851-855
3. 1 supplementation on vitamin K status in cystic fibrosis patients J Ped Gastroenterol Nutr 24 1997 512-527
4. Cornelissen E.A.M. Lieburg van A.F. Motohara K. Oostrom van C.G. Vitamin K status in cystic fibrosis Acta Paediatr 81 1992 658-661
5. Suttie L.W. Vitamin K and human nutrition J Am Diet Assoc 92 1992 585-590
6. Motohara K. Kuroki Y. Kan H. Endo F. Matsuda I. Detection of vitamin K deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin Pediatr Res 19 1985 354-357
7. Szulc P. Chapuy M.C. Meunier P.J. Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study Bone 18 1996 487-488
8. Shearer M.J. Vitamin K Lancet 345 1995 229-234
9. Vermeer C. Knapen M.H.J. Schurgers L.J. Vitamin K and metabolic bone disease J Clin Pathol 51 1998 424-426
10. Saupe J. Shearer M.J. Kohlmeier M. Phylloquinone transport and its influence on γ-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis Am J Clin Nutr 58 1993 204-208
11. Stulc T. Ceska R. Horinek A. Stepan J. Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotype Physiol Res 49 2000 435-439
12. 1 status in human liver samples: a search for inter-individual differences of warfarin sensitivity Brit J Haematol 84 1993 681-685
13. 1) in plasma using high-performance liquid chromatography with dual-electrode electrochemical detection Analyst 110 1985 1181-1184
14. Sadowski J.A. Hood S.J. Dallal G.E. Garry P.J. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration Am J Clin Nutr 50 1989 100-108
15. Knapen M.H. Hamulyak K. Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion Ann Intern Med 111 1989 1001-1005
16. Beker L.T. Fink R.J. Shamsa F.H. Chaney H.R. Kluft J. Evans E. Schidlow D.V. Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis J Pediatr Gastroenterol Nutr 19 1994 191-197
17. Rashid M. Durie P. Andrew M. Kalnins D. Shin J. Corey M. Tullis E. Pencharz P.B. Prevalence of vitamin K deficiency in cystic fibrosis Am J Clin Nutr 70 1999 378-382
18. Grundberg C.M. Nieman S.D. Abrams S. Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin J Clin Endocrinol Metab 83 1998 3258-3266
19. Kohlmeier M. Saupe J. Schaefer K. Asmus G. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype Calcif Tissue Int 62 1998 278-281
20. Lambert J.P. Osteoporosis: a new challenge in cystic fibrosis Pharmacotherapy 20 2000 34-52
21. Koletzko B. Koletzko S. Ernährung bei Cystischer Fibrose In: Reinhardt D. Götz M. Kraemer R. Schöni M.H. editors. Cystische Fibrose 2001 476 Springer Berlin
22. Carr S.B. McBratney J. The role of vitamins in cystic fibrosis J R Soc Med 93 2000 14-19